You may have heard of facial recognition technology but what about face recognition for cells in your body? This is one of the many technologies that Recursion Pharmaceuticals uses as part of its industrialisation of drug discovery. Deep learning algorithms can tell the difference between health and diseased human cells and use this to identify new medicines.
“The opportunity is to industrialise drug discovery,” says Recursion Pharmaceuticals’ president Tina Larson. “The best of the tech industry and the best of all of these tools - like CRISPR - that are in the life science industry now, to really change the way we discover medicine.”
Tina Larson, President, Recursion Pharmaceuticals was in conversation with Ashley McKimm, Editor-in-chief of BMJ Innovations at the British Medical Journal on the HealthConf stage at Web Summit 2021.
"The best technology conference on the planet".
Join us in Lisbon this November.